Investor Relations

Recent Event

Special Meeting of Shareholders

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2018

Company Overview

Conversion Labs, Inc. (the "Company") is a health and wellness focused e-commerce company with a portfolio of online direct-to-consumer brands. Our portfolio of brands includes proprietary over-the-counter products as well as over 1000 prescription medications we are licensed to sell in all 50 states and the District of Columbia through our joint venture partner, GoGoMeds.com. We also provide online physician consultations directly to consumers in all 50 states. In addition to our healthcare platform, Conversion Labs owns 51% of PDFSimpli, an online direct-response software as a service business that allows users to convert, edit, sign and share PDF files.

Investor Contact Information

Company

Conversion Labs, Inc.
800 Third Avenue
Suite 2800
New York, NY 10022
Toll-Free: (866) 351-5907
[email protected]

Investor Relations

Conversion Labs Investor & Media Relations Contact:
Ron Both, CMA
Email Contact
T: 949-432-7566

Transfer Agent

Worldwide Stock Transfer, LLC
One University Plaza, Suite 505
Hackensack, NJ 07601